Principles of Pharmacogenetics: Types of Genetic Variants
Genome-wide Association Studies-GWAS
Comparing Copy Number Variations and SNPs
Human Genetics
Pharmacogenomics: Identification of New Drug Targets
Incomplete Dominance
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 17, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
1Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. lukeward@mit.edu
Advances in functional genomics and regulatory mapping are unlocking the potential of noncoding genetic variants for understanding complex diseases. This enables personalized genomic risk assessment and diagnosis.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: